PharmAust Ltd (PAA)

0.089
-0.001(-1.11%)
  • Volume:
    10,000
  • Bid/Ask:
    0.089/0.090
  • Day's Range:
    0.089 - 0.089

PAA Overview

Prev. Close
0.09
Day's Range
0.089-0.089
Revenue
3.6M
Open
0.089
52 wk Range
0.081-0.12
EPS
-0.01
Volume
10,000
Market Cap
28.52M
Dividend (Yield)
N/A
(N/A)
Average Volume (3m)
155,035
P/E Ratio
-
Beta
1.13
1-Year Change
-6.32%
Shares Outstanding
316,912,383
Next Earnings Date
-
What is your sentiment on PharmAust Ltd?
or
Market is currently closed. Voting is open during market hours.

PharmAust Ltd News

PharmAust Ltd Company Profile

PharmAust Ltd Company Profile

Employees
0
Market
Australia

Pharmaust Limited is an Australia-based clinical-stage pharmaceutical company. The Company is focused on developing therapeutics for cancer, neurodegenerative diseases and viral infections in humans and cancer for pet dogs. The Company's lead candidate, monepantel (MPL), is a small molecule drug primarily being developed as a safe and potent treatment for cancer. The MPL can also be used for neurodegenerative diseases such as Motor Neuron Disease, Parkinson's Disease, and Alzheimer's Disease. It has completed Phase I clinical trials with MPL in humans and dogs diagnosed with solid tumors. The Company has also initiated a preclinical program to screen its portfolio of aminoacetonitrile (AAD) compounds for anticancer activity.

Read More

Technical Summary

Type
5 Min
15 Min
Hourly
Daily
Monthly
Moving AveragesNeutralNeutralSellStrong SellStrong Sell
Technical IndicatorsStrong SellStrong SellStrong SellStrong SellStrong Sell
SummarySellSellStrong SellStrong SellStrong Sell